Загрузка...
Systemic Sunitinib Malate Treatment for Advanced Juxtapapillary Retinal Hemangioblastomas Associated with von Hippel-Lindau Disease
PURPOSE: To describe the clinical course of advanced juxtapapillary retinal capillary hemangioblastomas (RCH) associated with von Hippel-Lindau (VHL) disease treated with systemic sunitinib malate, an agent that inhibits both anti-vascular endothelial growth factor and anti-platelet-derived growth f...
Сохранить в:
| Опубликовано в: : | Ophthalmol Retina |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5490440/ https://ncbi.nlm.nih.gov/pubmed/28670632 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.oret.2016.10.007 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|